Therapeutic effects of nitric oxide-aspirin hybrid drugs

Catriona M Turnbull, Adriano G Rossi, Ian L Megson

Research output: Contribution to journalReview articlepeer-review

13 Citations (Scopus)


This review examines the therapeutic potential and mechanisms of action of drugs known as nitric oxide (NO)-aspirins. Drugs of this class have an NO-releasing moiety joined by ester linkage to the aspirin molecule. NO-aspirins have the capability to release NO in addition to retaining the cyclooxygenase-inhibitory action of aspirin. The protective nature of NO led to the development of NO-aspirins in the hope that they might avoid the gastric side effects associated with aspirin. However, it has become apparent that the drug-derived NO instills potential for a wide range of added beneficial effects over the parent compound. In this review, the authors focus on the analgesic, anti-inflammatory, cardiovascular and chemopreventative actions of compounds of this emerging drug class.
Original languageEnglish
Pages (from-to)911-22
Number of pages12
JournalExpert Opinion on Therapeutic Targets
Issue number6
Publication statusPublished - 2006


Dive into the research topics of 'Therapeutic effects of nitric oxide-aspirin hybrid drugs'. Together they form a unique fingerprint.

Cite this